glutaminase has been researched along with Neuroendocrine-Tumors* in 1 studies
1 other study(ies) available for glutaminase and Neuroendocrine-Tumors
Article | Year |
---|---|
Glutaminases in slowly proliferating gastroenteropancreatic neuroendocrine neoplasms/tumors (GEP-NETs): Selective overexpression of mRNA coding for the KGA isoform.
Glutamine (Gln) is a crucial metabolite in cancer cells of different origin, and the expression and activity of different isoforms of the Gln-degrading enzyme, glutaminase (GA), have variable implications for tumor growth and metabolism. Human glutaminases are encoded by two genes: the GLS gene encodes the kidney-type glutaminases, KGA and GAC, while the GLS2 gene encodes the liver-type glutaminases, GAB and LGA. Recent studies suggest that the GAC isoform and thus high GAC/KGA ratio, are characteristic of highly proliferating tumors, while GLS2 proteins have an inhibitory effect on tumor growth. Here we analyzed the expression levels of distinct GA transcripts in 7 gastroenteropancreatic neuroendocrine tumors (GEP-NETs) with low proliferation index and 7 non-neoplastic tissues. GEP-NETs overexpressed KGA, while GAC, which was the most abundant isoform, was not different from control. The expression of the GLS2 gene showed tendency towards elevation in GEP-NETs compared to control. Collectively, the expression pattern of GA isoforms conforms to the low proliferative capacity of GEP-NETs encompassed in this study. Topics: Adult; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; Gene Silencing; Glutaminase; Humans; Intestinal Neoplasms; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Protein Isoforms; RNA, Messenger; Stomach Neoplasms | 2016 |